Elevated blood levels of uric acid are associated with a higher risk of pulmonary arterial hypertension (PAH) at the genetic level, a data study reported. “Overall, this study confirmed, from a genetic perspective, the causal relationship between serum UA [uric acid] levels and PAH,” the researchers wrote. They also…
The Pulmonary Hypertension Association (PHA) will host two events the last weekend of October to raise awareness about pulmonary hypertension (PH), seek funding, and support the PH community in anticipation of PH Awareness Month, which happens every…
Treatment with mosliciguat, an inhaled medication given once-daily for pulmonary hypertension (PH), can safely reduce the resistance against blood flow in blood vessels of the lungs, according to a Phase 1 clinical trial. This reduction in pulmonary vascular resistance (PVR) is one of the highest seen in PH…
Get regular updates to your inbox.